Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimodipine for postoperative facial nerve weakness after cerebellopontine angle tumor surgery
IRCT20120527009878N8Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of nimodipine in facial palsy (2 arms), sponsored by Tabriz University of Medical Sciences. Started Jun 2019; status: completed.
02
Drugs
nimodipine
03
Conditions
facial palsy
Beyond the preview
Go deeper on IRCT20120527009878N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120527009878N8.